| Autor: |
Hatanaka T; Department of Medical Affairs, Medical Division, GlaxoSmithKline KK, Akasaka, Minato-ku, Tokyo, Japan., Lulic Z; Pharma Research and Development, Global Medical, GlaxoSmithKline, Brentford, Middlesex, UK., Mefo T; Personalised Medicine - Pharmacogenomics Division, Epistem Ltd, Manchester, UK., Booth C; Personalised Medicine - Pharmacogenomics Division, Epistem Ltd, Manchester, UK., Harrison E; Personalised Medicine - Pharmacogenomics Division, Epistem Ltd, Manchester, UK., Ong G; Pharma Research and Development, Global Medical, GlaxoSmithKline Pte Ltd, Singapore. |
